The University of Pittsburgh, a major public research university, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Institute of Allergy and Infectious Diseases valued at $146.3 million. This IDC supports the development of preclinical models for infectious diseases, including work in small animal models, non-human primate models, animal replacement models, and specialized reagent generation. The contract allows for task orders supporting research, treatment, and...
The University of Pittsburgh holds an Indefinite Delivery Contract (IDC) from the National Institute of Allergy and Infectious Diseases (NIAID) to provide preclinical models of infectious diseases. This $146.3 million single-award IDC enables NIAID to rapidly initiate new preclinical studies in support of its mission to research, treat and prevent infectious diseases, with a focus on areas like pandemic preparedness and emerging threats. Under this IDC, which runs through 2031, Pitt is...
The University of Pittsburgh, a state-related research university, was awarded a single-award Indefinite Delivery Contract (IDC) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, valued at $146.3 million. This IDC, which runs through 2031, enables NIAID to rapidly initiate new preclinical studies in support of its mission to research, treat, and prevent infectious diseases, with a focus on areas like pandemic preparedness and emerging threats. Under...
The University of Pittsburgh, a state-related research university, was awarded an Indefinite Delivery Contract (IDC) by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services. The $40 million, multiple-award contract runs through July 2024 and is focused on providing preclinical models of infectious diseases. Under this IDC, the University of Pittsburgh is responsible for developing and employing animal and animal replacement...
The University of Pittsburgh has been awarded an Indefinite Delivery Contract (IDC) from the National Institute of Allergy and Infectious Diseases (NIAID) to provide preclinical models of infectious diseases. The $146.3 million single-award IDC, which runs through 2031, enables NIAID to rapidly initiate new preclinical studies in support of its mission to research, treat and prevent infectious diseases, with a focus on areas like pandemic preparedness and emerging threats. Under this IDC, Pitt...
The University of Pittsburgh - Of The Commonwealth System of Higher Education has been awarded a federal Indefinite Delivery Contract (IDC) from the Department of Veterans Affairs' Veterans Integrated Service Network 4 (VISN 4). This single-award IDC has a ceiling value of $2,796,836.33 and an ultimate completion date of June 30, 2026. The University of Pittsburgh, a major public research university, will provide DLAR (Deployment and Logistics Assistance for Research) services to VISN 4 under...
The University of Pittsburgh - Of The Commonwealth System of Higher Education has been awarded an Indefinite Delivery Contract (IDC) by the U.S. Department of Veterans Affairs (VA) to provide Research Infrastructure and Virtual Resources (RIVR) services at the Pittsburgh VA Health System and other VA sites. The contract has a ceiling value of $431,006 and was awarded on April 1, 2020, with an ultimate completion date of January 3, 2026. This single-award IDC does not have a set-aside...
The University of Pittsburgh, a state-related research university, was awarded an Indefinite Delivery Contract (IDC) by the Defense Health Agency (DHA), a component of the U.S. Department of Defense. This $2,500 Firm Fixed Price delivery order contract under the OMNIBUS IV program supports military medical research and development services. The OMNIBUS IV IDC is designed to enhance the DoD's medical research and development programs, covering a broad range of health-related R&D and support...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $146,300,000 single-award Indefinite Delivery Contract (IDC) to the University of Pittsburgh for the "Pre-Clinical Models of Infectious Diseases - Task Areas A and B" program. The contract has a period of performance through July 2031. The IDC aims to provide NIAID with the capability and capacity to develop and employ animal and animal replacement models of infectious diseases for...
The University of Pittsburgh has been awarded a $978,069 Other Transaction (OT) Indefinite Delivery Vehicle (IDV) contract by the Defense Advanced Research Projects Agency (DARPA). This OT IDV, which has no set-aside designation, enables DARPA to rapidly initiate new preclinical studies in support of its mission to research, treat, and prevent infectious diseases, with a focus on areas like pandemic preparedness and emerging threats. Under this OT IDV, which runs through 2031, the University...